1. Home
  2. PBYI vs FEIM Comparison

PBYI vs FEIM Comparison

Compare PBYI & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • FEIM
  • Stock Information
  • Founded
  • PBYI 2010
  • FEIM 1961
  • Country
  • PBYI United States
  • FEIM United States
  • Employees
  • PBYI N/A
  • FEIM N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • FEIM Electrical Products
  • Sector
  • PBYI Health Care
  • FEIM Industrials
  • Exchange
  • PBYI Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • PBYI 126.5M
  • FEIM 119.5M
  • IPO Year
  • PBYI N/A
  • FEIM N/A
  • Fundamental
  • Price
  • PBYI $2.61
  • FEIM $11.94
  • Analyst Decision
  • PBYI Strong Buy
  • FEIM
  • Analyst Count
  • PBYI 1
  • FEIM 0
  • Target Price
  • PBYI $7.00
  • FEIM N/A
  • AVG Volume (30 Days)
  • PBYI 295.8K
  • FEIM 65.8K
  • Earning Date
  • PBYI 10-31-2024
  • FEIM 09-10-2024
  • Dividend Yield
  • PBYI N/A
  • FEIM 8.39%
  • EPS Growth
  • PBYI N/A
  • FEIM N/A
  • EPS
  • PBYI 0.18
  • FEIM 0.62
  • Revenue
  • PBYI $219,143,000.00
  • FEIM $57,943,000.00
  • Revenue This Year
  • PBYI N/A
  • FEIM N/A
  • Revenue Next Year
  • PBYI N/A
  • FEIM N/A
  • P/E Ratio
  • PBYI $13.51
  • FEIM $19.50
  • Revenue Growth
  • PBYI N/A
  • FEIM 28.82
  • 52 Week Low
  • PBYI $2.13
  • FEIM $6.93
  • 52 Week High
  • PBYI $7.73
  • FEIM $14.50
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 49.31
  • FEIM 44.26
  • Support Level
  • PBYI $2.41
  • FEIM $11.90
  • Resistance Level
  • PBYI $2.69
  • FEIM $12.46
  • Average True Range (ATR)
  • PBYI 0.13
  • FEIM 0.33
  • MACD
  • PBYI 0.03
  • FEIM -0.02
  • Stochastic Oscillator
  • PBYI 64.25
  • FEIM 44.94

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: